Aug 26, 2022 by Lukas BarfieldCresco Labs Gets Closer to Its Massive Deal With Columbia CareThe new cannabis company will have a unrivaled reach.
Aug 18, 2022 by Lukas BarfieldCan Trulieve Recover From the Harvest Deal?Its footprint grew, while its stock price fell.
Aug 13, 2022 by Lukas BarfieldCan Innovative Industrial Properties Survive the Remainder of 2022?It's counting on new investments in tough economic times.
Aug 5, 2022 by Lukas BarfieldWhy Tilray Can't Count on Cannabis For NowAs it waits for the regulatory haze to clear, the cannabis company's booking bigger growth from other product lines.
Jul 29, 2022 by Lukas Barfield2 Reasons Verano's Ready for U.S. Cannabis LegalizationIf Congress can make cannabis legal nationwide -- a big if -- this multistate operator looks prepared to profit.
Jul 26, 2022 by Lukas Barfield22nd Century Group's Road to Cannabis May Have Some PotholesThe biotechnology company is working hard to get up to speed, but it risks running out of highway.
Jul 10, 2022 by Lukas BarfieldTerrAscend Turns Its First Profit as Revenues RiseSG&A spending helped the cannabis company achieve those gains.
Jun 28, 2022 by Lukas Barfield2 Reasons Aurora Could Recover From Significant PruningThe cannabis company's down, but far from out.
Jun 22, 2022 by Lukas BarfieldHow Green Thumb's Big Spending in 2021 Could Pay OffWith those costs coming back down to Earth, the cannabis operator may be ready to harvest what it's planted.
Jun 9, 2022 by Lukas BarfieldYet Another Lawsuit Adds to Curaleaf's TroublesA new class action case could compound the multistate operator's woes.
